Lipopolysaccharide (LPS) may play an important role in chronic diseases through the activation of inflammatory responses. The type of diet consumed is of major concern for the prevention and treatment of these diseases. Evidence from animal and human studies has shown that LPS can diffuse from the gut to the circulatory system in response to the intake of high amounts of fat. The method by which LPS move into the circulatory system is either through direct diffusion due to intestinal paracellular permeability or through absorption by enterocytes during chylomicron secretion. Considering the impact of metabolic diseases on public health and the association between these diseases and the levels of LPS in the circulatory system, this review will mainly discuss the current knowledge about high-fat diets and subclinical inflammation. It will also describe the new evidence that correlates gut microbiota, intestinal permeability and alkaline phosphatase activity with increased blood LPS levels and the biological effects of this increase, such as insulin resistance. Although the majority of the studies published so far have assessed the effects of dietary fat, additional studies are necessary to deepen the understanding of how the amount, the quality and the structure of the fat may affect endotoxaemia. The potential of food combinations to reduce the negative effects of fat intake should also be considered in future studies. In these studies, the effects of flavonoids, prebiotics and probiotics on endotoxaemia should be investigated. Thus, it is essential to identify dietetic strategies capable of minimising endotoxaemia and its postprandial inflammatory effects.Key words: High-fat diets: Lipopolysaccharides: Gut microbiota: Intestinal permeabilityThe role of gut microbiota in the development of diseases such as obesity (1) , diabetes (2) and atherosclerosis (3) has received increased attention from researchers worldwide. These diseases share a common mechanism because the activation of the immune system leads to greater inflammation (4 -9) . Components originating from gut microbiota, such as lipopolysaccharide (LPS), lipoteichoic acid, peptidoglycan, flagellin and bacterial DNA, can cause immune system activation. LPS is thought to be a major inducer of the inflammatory response, suggesting a possible association between intestinal LPS and these metabolic diseases (10 -13) .LPS is one of the main components of the external cell wall of Gram-negative bacteria. Therefore, the gut microbiota is a huge reservoir of this endotoxin (14) . There are 10 12 bacterial cells in each gram of faeces (15) . Consequently, it is possible to detect more than 1 g of LPS in the intestinal lumen (16,17) . Under normal conditions, the presence of LPS in the intestinal lumen does not cause negative health effects (18) . However, some factors can favour the transfer of LPS into the circulatory system. It has been suggested that the type of diet consumed, especially high-fat diets, can contribute to endotoxaemia, which is caused b...